Ardelyx, Inc.

Ardelyx, Inc.

Biotechnology Research United States 460 employees
Employees
460
Contacts
3
Emails
3
Phones
1

Ardelyx, Inc. Overview

Headquarters
United States
Phone Number
Available in AeroLeads
Website
ardelyx.com
Industry
Biotechnology Research
Employees
460
Founded
2007
Funding
20.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Ardelyx, Inc.

Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Community Guidelines: https://rb.gy/07ltg3

Ardelyx, Inc. Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

Ardelyx, Inc. Org Chart

Sample employees and titles
Name Title Contact
Andrea Goff Area Business Director (Gastroenterolgy)
Email
Dane Hartung Market Access / Patient Services / Us
Email
Maria Umali Giordano Executive Director, Quality Management
View
Willi Huang Executive Advisor - Supply Chain
Email Phone

Employees by Management Level

Individual contributor 24 profiles
Director 22 profiles
Manager 7 profiles
Executive 1 profile

Department Contact Coverage

Department Contacts Email Phone
Sales 8 8 3
General 7 7 2
Executive 5 5 2
Healthcare 5 5 1
Marketing 3 3 3
Operations 1 1 1

Ardelyx, Inc. Tech Stack

Data / AI 2 profiles

Compare Similar Companies to Ardelyx, Inc.